The Effect of Therapy on Mature Height in Congenital Adrenal Hyperplasia*
The DOI matches its Crossref record.
Abstract
The effects of therapy on the final height of children with congenital adrenal hyperplasia (CAH) were evaluated. Forty-six children with the 21-hydroxylase defect, 30 of whom had defects in electrolyte metabolism, were followed to maturity. In group A, there were 19 children (11 females and 8 males) who were diagnosed and adequately treated at less than 3 yr of age. In group B, there were 9 children (8 females and 1 male) who were adequately treated, but treatment was begun after 3 yr of age. In group C, there were 15 children (10 females and 5 males) whose treatment was inadequate. In group D, there were 3 female pseudohermaphrodites reared as males. The mean ages at diagnosis were: group A, 0.60 yr (±0.79 sd); group B, 6.43 yr (±2.96 sd); and group C, 4.96 yr (±5.19 sd). The group A males (final height, 171.9 cm ± 2.8 se) and females (final height, 162.5 cm ± 1.6 se) were significantly taller than the corresponding group C children (males, 160.14 cm ± 2.4 se, P < 0.01; females, 145.64 cm ± 2.89 se, P < 0.005) as regards mean final height. Group B females (159.86 cm ± 2.5 se) did not differ significantly from group A females in mean final height, but group B females were different from the U.S mean for females (18.25–19 yr; P < 0.05). Group A males and group A females were not significantly different from the U.S. mean for males and females, respectively (18.25–19 yr; P > 0.05 and P > 0.1, respectively). Group C males and females were significantly different from the U.S. mean for respective males or females 18.25–19 yr (P < 0.001). Group A females were not significantly different from group D subjects (162.35 cm ± 3.8 se). Anticipated final height of the females in Group B may reflect the different treatment method or the possibility that they may have a milder form of the disease. The patients who were adequately treated had greater final heights than those who were inadequately treated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182
“Comparison with other reviews Final adult height is influenced by many factors, namely age at diagnosis (38), dose of glucocorticoid therapy (39), adequacy of treatment (13), and form of CAH (25).”
BackgroundAdrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Bonfig, W., Bechtold, S., Schmidt, H., Knorr, D., & Schwarz, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2109 · Cited by 167
Bonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., & Schwarz, H. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0942 · Cited by 136
Metadata
- Authors
- KIRKLAND, R. T., KEENAN, B. S., HOLCOMBE, J. H., KIRKLAND, J. L., & CLAYTON, G. W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1978-12
- Volume
- 47
- Issue
- 6
- Pages
- 1320-1324
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2002176243
- Cited by
- 52
- References
- 0
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Therapy on Mature Height in Congenital Adrenal Hyperplasia*. https://app.cochat.ai/papers/10.1210/jcem-47-6-1320
- The paper
- KIRKLAND, R. T., KEENAN, B. S., HOLCOMBE, J. H., KIRKLAND, J. L., & CLAYTON, G. W. (1978). The Effect of Therapy on Mature Height in Congenital Adrenal Hyperplasia*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-47-6-1320
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.